The Hourly View for Pfizer

• At the time of this writing, PFE’s price is down $-0.03 (-0.06%) from the hour prior.
• Pfizer has seen its price go down 4 out of the past 5 hours, thus creating some compelling opportunities for bears.
• If you’re a trend trader, consider that the strongest clear trend on the hourly chart exists on the 50 hour timeframe.
• Price action traders may also wish to note that we see a doji candlestick pattern on Pfizer. Given that we see downtrend on the 10 hourly candle timeframe, and that such candlestick patterns often denote reversals, this may be worth noting.
• The moving averages on the hourly timeframe suggest a choppiness in price, as the 20, 50, 100 and 200 are all in a mixed alignment — meaning the trend across timeframes is inconsistent, indicating a potential opportunity for rangebound traders.

Pfizer’s hourly price chart is shown below.

The Daily View for Pfizer

• Currently, PFE’s price is down $-0.31 (-0.69%) from the day prior.
• The daily chart shows that Pfizer has seen 3 straight down days.
• If you’re a trend trader, consider that the strongest clear trend on the daily chart exists on the 50 day timeframe.
• The moving averages on the daily timeframe suggest a bullishness in price, as the 20, 50, 100 and 200 are all in a bullish alignment — meaning the shorter durations are above the longer duration averages, implying a sound upward trend.
• Divergence alert: Trend in PFE’s price and its RSI are diverging. PFE’s price is rising faster than its RSI.

Below is a daily price chart of Pfizer.

Latest News Discussing PFE

• United Airlines Demands Employees Get COVID-19 Vaccinations Or Risk Being Fired – Phil Hall
  August 6, 2021

  United Airlines Holdings Inc. (NASDAQ: UAL) has a message for its 67,000-member U.S. workforce: get vaccinated against COVID-19 or get a job elsewhere.
  What Happened: United CEO Scott Kirby and President Brett Hart sent an internal memo to the air…

  Related Articles

• Tracking Kahn Brothers Portfolio – Q2 2021 Update – John Vincent
  August 6, 2021

  Kahn Brothers’ 13F portfolio value increased from $646M to $698M this quarter. BP plc and Pfizer were increased while decreasing Nam Tai Property and BlackBerry during the quarter.

• Pharma Stock Roundup: LLY, NVO, BAYRY Q2 Earnings, SNY’s TBIO Buyout, FDA Updates – Kinjel Shah
  August 6, 2021

  Lilly (LLY), Novo Nordisk (NVO) and Bayer (BAYRY) announce Q2 results. FDA approves AstraZeneca’s (AZN) lupus medicine, Saphnelo. Sanofi (SNY) to buy Translate Bio.

The post Pfizer is on a Tear — Due for a Pullback? appeared first on CFDTrading.